|
1
|
Lowe HI, Watson CT, Badal S, et al:
Cycloartane-3,24,25-triol inhibits MRCKα kinase and demonstrates
promising anti prostate cancer activity in vitro. Cancer Cell Int.
12:462012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, et al: Cancer incidence and mortality patterns
in Europe: estimates for 40 countries in 2012. Eur J Cancer.
49:1374–1403. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Berthold DR, Sternberg CN and Tannock IF:
Management of advanced prostate cancer after first-line
chemotherapy. J Clin Oncol. 23:8247–8252. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Diantini A, Subarnas A, Lestari K, et al:
Kaempferol-3-O-rhamnoside isolated from the leaves of Schima
wallichii Korth inhibits MCF-7 breast cancer cell proliferation
through activation of the caspase cascade pathway. Oncol Lett.
3:1069–1072. 2012.PubMed/NCBI
|
|
6
|
Mao YW, Tseng HW, Liang WL, et al:
Anti-inflammatory and free radial scavenging activities of the
constituents isolated from Machilus zuihoensis. Molecules.
16:9451–9466. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hall A: Rho GTPases and the actin
cytoskeleton. Science. 279:509–514. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heikkila T, Wheatley E, Crighton D, et al:
Co-crystal structures of inhibitors with MRCKβ, a key regulator of
tumor cell invasion. PloS One. 6:e248252011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jaffe AB and Hall A: Rho GTPases:
biochemistry and biology. Annu Rev Cell Dev Biol. 21:247–269. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wilkinson S, Paterson HF and Marshall CJ:
Cdc42-MRCK and Rho-ROCK signaling cooperate in myosin
phosphorylation and cell invasion. Nat Cell Biol. 7:255–261. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fritz G, Just I and Kaina B: Rho GTPases
are over-expressed in human tumors. Int J Cancer. 81:682–687. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Riento K and Ridley AJ: Rocks:
multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol.
4:446–456. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakajima M, Hayashi K, Egi Y, et al:
Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16
melanoma. Cancer Chemother Pharmacol. 52:319–324. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakajima M, Hayashi K, Katayama K, et al:
Wf-536 prevents tumor metastasis by inhibiting both tumor motility
and angiogenic actions. Eur J Pharmacol. 459:113–120. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakajima M, Katayama K, Tamechika I, et
al: WF-536 inhibits metastatic invasion by enhancing the host cell
barrier and inhibiting tumour cell motiltiy. Clin Exp Pharmacol
Physiol. 30:457–463. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Genda T, Sakamoto M, Ichida T, et al: Cell
motility mediated by rho and Rho-associated protein kinase plays a
critical role in intrahepatic metastasis of human hepatocellular
carcinoma. Hepatology. 30:1027–1036. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takamura M, Sakamoto M, Genda T, et al:
Inhibition of intrahepatic metastasis of human hepatocellular
carcinoma by Rho-associated protein kinase inhibitor Y-27632.
Hepatology. 33:577–581. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ying H, Biroc SL, Li WW, et al: The Rho
kinase inhibitor fasudil inhibits tumor progression in human and
rat tumor models. Mol Cancer Ther. 5:2158–2164. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bemis DL, Capodice JL, Desai M, et al: A
concentrated aglycone isoflavone preparation (GCP) that
demonstrates potent anti-prostate cancer activity in vitro and in
vivo. Clin Cancer Res. 10:5282–5292. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ngamwongsatit P, Banada PP, Panbangred W
and Bhunia AK: WST-1-based cell cytotoxicity assay as a substitute
for MTT-based assay for rapiddetection of toxigenic Bacillus
species using CHO cell line. J Microbiol Meth. 73:211–215. 2008.
View Article : Google Scholar
|
|
21
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Olson MF and Sahai E: The actin
cytoskeleton in cancer cell motility. Clin Exp Metastasis.
26:273–287. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Banyard J, Anand-Apte B, Symons M and
Zetter BR: Motility and invasion are differentially modulated by
Rho family GTPases. Oncogene. 19:580–591. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hall A: The cytoskeleton and cancer.
Cancer Metastasis Rev. 28:5–14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Morgan Fisher, Wewer UM and Yoneda A:
Regulation of ROCK activity in cancer. J Histochem Cytochem.
61:185–198. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Amano M, Nakayama M and Kaibuchi K:
Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell
polarity. Cytoskeleton (Hoboken). 67:545–554. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gurkar AU, Chu K, Raj L, et al:
Identification of ROCK1 kinase as a critical regulator of
Beclin1-mediated autophagy during metabolic stress. Nat Commun.
4:21892013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Edwards DC, Sanders LC, Bokoch GM and Gill
GN: Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase
signalling to actin cytoskeletal dynamics. Nat Cell Biol.
1:253–259. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ohashi K, Nagata K, Maekawa M, Ishizaki T,
Narumiya S and Mizuno K: Rho associated kinase ROCK activates
LIM-kinase 1 by phosphorylation at threonine 508 within the
activation loop. J Biol Chem. 275:3577–3582. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sumi T, Matsumoto K, Shibuya A and
Nakamura T: Activation of LIM kinases by myotonic dystrophy
kinase-related Cdc42-binding kinase alpha. J Biol Chem.
276:23092–23096. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dan C, Kelly A, Bernard O and Minden A:
Cytoskeletal changes regulated by the PAK4 serine/threonine kinase
are mediated by LIM kinase 1 and cofilin. J Biol Chem.
276:32115–32121. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vlecken DH and Bagowski CP: LIMK1 and
LIMK2 are important for metastatic behavior and tumor cell-induced
angiogenesis of pancreatic cancer cells. Zebrafish. 6:433–439.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yoshioka K, Foletta V, Bernard O and Itoh
K: A role for LIM kinase in cancer invasion. Proc Natl Acad Sci
USA. 100:7247–7252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bagheri Yarmand, Mazumdar A, Sahin AA and
Kumar R: LIM kinase 1 increases tumor metastasis of human breast
cancer cells via regulation of the urokinase-type plasminogen
activator system. Int J Cancer. 118:2703–2710. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Z, ElSohly HN, Li XC, et al:
Phenolic compounds from Nymphaea odorat. J Nat Prod.
66:548–550. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shin SW, Jung E, Kim S, Kim JH, Kim EG,
Lee J and Park D: Antagonizing effects and mechanisms of afzelin
against UVB-induced cell damage. PLoS One. 8:e619712013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou W and Nie X: Afzelin attenuates
asthma phenotypes by downregulation of GATA3 in a murine model of
asthma. Mol Med Rep. 12:71–76. 2015.PubMed/NCBI
|
|
38
|
Benitaha SA, Valeróna PF, Aelstb L,
Marshallc CJ and Lacala JC: Rho GTPases in human cancer: an
unresolved link to upstream and downstream transcriptional
regulation. Biochimicaet Biophysica Acta. 1705:121–132. 2005.
|
|
39
|
Balasenthil S, Chen N, Lott ST, et al: A
migration signature and plasma biomarker panel for pancreatic
adenocarcinoma. Cancer Prev Res (Phila). 4:137–149. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lefort K, Mandinova A, Ostano P, et al:
Notch1 is a p53 target gene involved in human keratinocyte tumor
suppression through negative regulation of ROCK1/2 and MRCK-alpha
kinases. Genes Dev. 21:562–577. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pyeon D, Newton MA, Lambert PF, et al:
Fundamental differences in cell cycle deregulation in human
papillomavirus-positive and human papillomavirus-negative head/neck
and cervical cancers. Cancer Res. 67:4605–4619. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schlingemann J, Habtemichael N, Ittrich C,
et al: Patient-based cross-platform comparison of oligonucleotide
microarray expression profiles. Lab Invest. 85:1024–1039. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ginos MA, Page GP, Michalowicz BS, et al:
Identification of a gene expression signature associated with
recurrent disease in squamous cell carcinoma of the head and neck.
Cancer Res. 64:55–63. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim SM, Park YY, Park ES, et al:
Prognostic biomarkers for esophageal adenocarcinoma identified by
analysis of tumor transcriptome. PLoS One. 5:e150742010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang S, Zhan M, Yin J, et al:
Transcriptional profiling suggests that Barrett's metaplasia is an
early intermediate stage in esophageal adenocarcinogenesis.
Oncogene. 25:3346–3356. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hao Y, Triadafilopoulos G, Sahbaie P, et
al: Gene expression profiling reveals stromal genes expressed in
common between Barrett's esophagus and adenocarcinoma.
Gastroenterology. 131:925–933. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kimchi ET, Posner MC, Park JO, et al:
Progression of Barrett's metaplasia to adenocarcinoma is associated
with the suppression of the transcriptional programs of epidermal
differentiation. Cancer Res. 65:3146–3154. 2005.PubMed/NCBI
|
|
48
|
Lourenço FC, Munro J, Brown J, et al:
Reduced LIMK2 expression in colorectal cancer reflects its role in
limiting stem cell proliferation. Gut. 63:480–493. 2014. View Article : Google Scholar : PubMed/NCBI
|
